On Friday, Following U.S. Stocks were among the “Top Losers”: Atwood Oceanics, (NYSE:ATW), United States Steel (NYSE:X), Synthetic Biologics (NYSEMKT:SYN), Meritor (NYSE:MTOR)
Atwood Oceanics, Inc (NYSE:ATW) released that its board of directors has uncovered a quarterly cash dividend of $0.25 for each share of ordinary stock, due on April 9, 2015 to investors of record as of 5:00 p.m., New York City time, on April 2, 2015.
Atwood Oceanics, Inc (NYSE:ATW) dipped -3.70%, and closed at $27.61. The company holds the market capitalization of 1.78 billion. For the trailing twelve months, the stock’s return on equity remains 12.20%, while return on assets is 7.00%, in response to its return on investment 8.90%. Its 20-day moving average decreased -12.41%, above 50-day moving average of -8.21%, below 200-day moving average of -30.69% from the latest market price of $27.61. The mean recommendation of analysts for this stock is 2.50. (Where 1=Buy, 5=Sale).
Atwood Oceanics, Inc (ATW) an offshore drilling contractor holds in the drilling and completion of exploratory and developmental oil and gas wells worldwide.
United States Steel Corporation (NYSE:X) declared it will temporarily idle its Minnesota Ore Operations – Keetac plant in Keewatin, Minn., effective May 13. The temporary idling is due to the corporation’s current inventory levels and ongoing adjustment of its steelmaking operations throughout North America to match customer demand.
United States Steel Corporation (NYSE:X) dropped -3.67%, and closed at $21.80. The company holds the market capitalization of 3.18 billion. For the trailing twelve months, the stock’s return on equity value remains 2.80%, while return on assets value is 0.80%, in response to its return on investment value of 4.70%. Its 20-day moving average decreased -9.44%, above 50-day moving average of -8.55%, below 200-day moving average of -28.34% from the latest market price of $21.80. The mean recommendation of analysts for this stock is 3.00. (Where 1=Buy, 5=Sale).
United States Steel Corporation (X) produces and sells flat-rolled and tubular steel products in North America and Europe. It works through three segments: Flat-Rolled Products (Flat-Rolled), U. S. Steel Europe (USSE), and Tubular Products (Tubular).
Synthetic Biologics Inc (NYSEMKT:SYN) stated financial results for the year ended December 31, 2014, and offered an operational update.
Established Clinical Advisory Board and strengthened intellectual property portfolio,
Accomplished Phase 1a and 1b clinical trials; stated positive top-line safety and tolerability data from both studies,
Plan to initiate a Phase 2a clinical trial to evaluate gastrointestinal (GI) antibiotic-degrading effects and safety (1Q 2015); expect top-line data (1H 2015).
Synthetic Biologics Inc (NYSEMKT:SYN)‘s shares dropped down -3.67%, and closed at $2.89. The stock volatility for the week is 12.21%, while for the month remained 8.75%. The company holds consensus target price of $4.75.
If we consider EPS growth of the company, then we will notice the following observations:
The company showed -0.31 diluted EPS growth for trailing twelve months. However, YTD EPS growth remained 46.00% and Annual EPS growth for the past 5 years is considered as 5.10%.
The mean recommendation of analysts for this stock is 1.70. (Where 1=Buy, 5=Sale).
Synthetic Biologics Inc (SYN) a biotechnology corporation focuses on development of novel anti-infective biologics and drug candidates targeting specific pathogens that cause serious infections and other diseases.
Meritor Inc (NYSE:MTOR), fell -3.50%, and closed at $13.25. The stock has the beta value of 2.62, and its volatility for the week is 2.63%, while for the month it is 2.28%. The company has the market capitalization of $1.31billion. The company holds the book value per share of -6.16, whereas cash per share is 2.17. Price to sale value is 0.35. Analysts mean recommendation for the stock is said to be 2.50 (where 1=Buy, 5=sale).
Meritor Inc (MTOR) designs, develops, manufactures, sells, markets, distributes, services, and supports integrated systems, modules, and components to original equipment producers (OEMs) and the aftermarket for the commercial vehicle, transportation, and industrial sectors.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
